Tisseel® as a Reinforcement of Esophagojejunal Anastomoses
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Background:
The dehiscence of esophagojejunal anastomoses is one of the most serious complications after
total gastrectomy in patients with gastric cancer. Any method of avoiding this problem will
affect not only the postoperative course but also the prognostic of disease.
Methods:
This is a prospective, randomized and multicenter trial, within the Spanish EURECCA
Esophagogastric Cancer Group, to investigate the efficacy of Tisseel® in reducing the rate of
esophagojejunal anastomosis leakage in patients with gastric cancer. The rate of anastomosis
leak will be measured with clinical, radiological and analytic parameters.
Objective:
Analyze the efficacy of Tisseel® as a reinforcement in reducing the rate of anastomotic
esophagojejunal anastomoses.